Frontiers in Immunology

Original Research

Published on 31 Jan 2025

Stemness-related gene signatures as a predictive tool for breast cancer radiosensitivity

in Cancer Immunity and Immunotherapy

Jinzhi Lai
Rongfu Huang
Jingshan Huang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1536284

123 views

Correction

Published on 31 Jan 2025

Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma

in Cancer Immunity and Immunotherapy

Chengcheng Zhang
Linling Wang
Qianzhen Zhang
Junjie Shen
Xia Huang
Meiling Wang
Yi Huang
Jun Chen
Yanmin Xu
Wenxu Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1548247

Review

Published on 31 Jan 2025

It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma

in Cancer Immunity and Immunotherapy

Christin Knickmeier
Gaetan Aime Noubissi Nzeteu
Bernhard F. Gibbs
Frederik J. H. Hoogwater
Maarten W. Nijkamp
Maximilian Bockhorn
N. Helge Meyer

Frontiers in Immunology

doi 10.3389/fimmu.2025.1495907

106 views

Correction

Published on 31 Jan 2025

Corrigendum: Brain-specific increase in leukotriene signaling accompanies chronic neuroinflammation and cognitive impairment in a model of Gulf War Illness

in Multiple Sclerosis and Neuroimmunology

Sahithi Attaluri
Raghavendra Upadhya
Maheedhar Kodali
Leelavathi N. Madhu
Dinesh Upadhya
Bing Shuai
Ashok K. Shetty

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557065

Case Report

Published on 31 Jan 2025

Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency

in Primary Immunodeficiencies

Anna Roppelt
Ulyana Markina
Irina Beloglazova
Vasily Parshin
Dmitry Kanner
Dmitry Pershin
Mariia Fadeeva
Elena Raykina
Maxim Aleksenko
Alexander Karaulov

Frontiers in Immunology

doi 10.3389/fimmu.2024.1523256

160 views

Systematic Review

Published on 31 Jan 2025

Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials

in Cancer Immunity and Immunotherapy

Ji Ren
Jinghe Wang
Yanan Wang
Dongying Yang
Jianming Sheng
Shili Zhu
Yunli Liu
Xiaoqi Li
Wei Liu
Binbin Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1521362

110 views

Review

Accepted on 30 Jan 2025

In-depth Analysis of the Safety of CAR-T Cell Therapy for Solid Tumors

in Cancer Immunity and Immunotherapy

Jiayi Dong
Wu Jiexiong
Ye Jin
Zhu Zheng
Ting Su
Lijuan Shao
Jiaxin Bei
Size Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1548979

Original Research

Accepted on 30 Jan 2025

Monocyte-derived Langerhans cells express Delta-like 4 induced by peptidoglycan and interleukin-4 mediated suppression

in Antigen Presenting Cell Biology

Rei Ono
Kohei Maeda
Toshihiro Tanioka
Takeo Isozaki

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532620

Original Research

Accepted on 30 Jan 2025

Measles vaccination in lung transplant candidates

in Alloimmunity and Transplantation

Mikhail P. Kostinov
Valentina B. Polishchuk
Аleksey A. Ryzhov
Pavel I. Zhuravlev
Natalia A. Karchevskaya
Evgeniy A. Tarabrin
Irina L. Solovieva
Alexander P. Cherdantsev
Izabella A. Khrapunova
Elena P. Foshina

Frontiers in Immunology

doi 10.3389/fimmu.2025.1481206

Original Research

Accepted on 30 Jan 2025

A Nomogram for Predicting Cancer-Specific Survival in Patients with Locally Advanced Unresectable Esophageal Cancer: Development and Validation Study

in Cancer Immunity and Immunotherapy

Liangyun Xie
Yafei Zhang
Xiedong Niu
Xiaomei Jiang
Kang Yuan
Xinyue Diao
Jinhai Fang
Yilin Yu
Jun Yao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524439

Review

Accepted on 30 Jan 2025

Role of Skin-homing T-cells in Recurrent Episodes of Atopic Dermatitis: A Review

in Inflammation

Huimin Guo
Huimin Yuan
Yanru Yu
Jingwei Sun
Yan Sun
Yang Tang
Fengjie Zheng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1489277

Perspective

Accepted on 30 Jan 2025

The Toll Like Receptor 7 Pathway and the Sex Bias of Systemic Lupus Erythematosus

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Robert Hal Scofield
Jonathan Daniel Wren
Valerie Lewis

Frontiers in Immunology

doi 10.3389/fimmu.2025.1479814

Review

Accepted on 30 Jan 2025

Ubiquitin Proteasome System: A Potential Participant and Therapeutic Target in Antiphospholipid Syndrome

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

He Wang
Yuan Tan
Qi Liu
Shuo Yang
Liyan Cui

Frontiers in Immunology

doi 10.3389/fimmu.2025.1523799

Review

Accepted on 30 Jan 2025

Big lessons from the little Akkermansia muciniphila in hepatocellular carcinoma

in Microbial Immunology

Yanguang Yang
Xinli Shi

Frontiers in Immunology

doi 10.3389/fimmu.2025.1524563

Original Research

Accepted on 30 Jan 2025

Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration

in Cancer Immunity and Immunotherapy

Haibin Wang
Liu Xinli
Hesen Huang
Meng Tang
Ji-Wei Li
Tingting Huang
Shengjie Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1510503

Review

Accepted on 30 Jan 2025

IFIT3: A Crucial Mediator in Innate Immunity and Tumor Progression with Therapeutic Implications

in Cancer Immunity and Immunotherapy

日罕乌
昊杨

Frontiers in Immunology

doi 10.3389/fimmu.2025.1515718

Navigation group

Articles

Stemness-related gene signatures as a predictive tool for breast cancer radiosensitivity

Corrigendum: Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma

It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma

Corrigendum: Brain-specific increase in leukotriene signaling accompanies chronic neuroinflammation and cognitive impairment in a model of Gulf War Illness

Case report: JAK inhibitor treatment of immune dysregulation symptoms in a patient with PTPN2 deficiency

Efficacy and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a meta-analysis with trial sequential analysis of randomized controlled trials

In-depth Analysis of the Safety of CAR-T Cell Therapy for Solid Tumors

Monocyte-derived Langerhans cells express Delta-like 4 induced by peptidoglycan and interleukin-4 mediated suppression

Measles vaccination in lung transplant candidates

A Nomogram for Predicting Cancer-Specific Survival in Patients with Locally Advanced Unresectable Esophageal Cancer: Development and Validation Study

Role of Skin-homing T-cells in Recurrent Episodes of Atopic Dermatitis: A Review

The Toll Like Receptor 7 Pathway and the Sex Bias of Systemic Lupus Erythematosus

Ubiquitin Proteasome System: A Potential Participant and Therapeutic Target in Antiphospholipid Syndrome

Big lessons from the little Akkermansia muciniphila in hepatocellular carcinoma

Multi-omics analysis identifies UBA family as potential pan-cancer biomarkers for tumor prognosis and immune microenvironment infiltration

IFIT3: A Crucial Mediator in Innate Immunity and Tumor Progression with Therapeutic Implications